Takahiro Nakayama
8PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 15, 2025
Real-world treatment outcomes of abemaciclib in older patients with HR+, HER2- metastatic breast cancer in Japan.Tatsunori Shimoi, Yoshinori Tanizawa, Long Jin
|Dec 21, 2024
CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in Japan.Takahiro Nakayama, Linghua Xu, Yasuaki Muramatsu
|Oct 02, 2023
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma
|Jul 24, 2023
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).Manabu Futamura, Takahiro Nakayama, Tetsuhiro Yoshinami
|May 04, 2023
Fifteen-year survival and conditional survival of women with breast cancer in Osaka, Japan: A population-based study.Mizuki Kato, Kayo Nakata, Toshitaka Morishima
|Sep 10, 2021
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.Norikazu Masuda, Tetsuhiro Yoshinami, Masahiko Ikeda
Pageof 2
Frequent Collaborators
4 joint publications
Fumie Fujisawa
3 joint publications
Norikazu Masuda
2 joint publications
Nobuyoshi Kittaka
1 joint publications
Yoshifumi Komoike
1 joint publications
Tsutomu Takashima
1 joint publications
Katsuhide Yoshidome
1 joint publications
Junji Tsurutani
1 joint publications
Jun Yamamura
1 joint publications
Mizuki Kato
1 joint publications
Kayo Nakata
